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The value of cytological diagnosis of small cell lung carcinoma
Znaczenie badania cytologicznego w rozpoznawaniu drobnokomórkowego raka płuca
Abstract
Introduction: Small cell lung carcinoma (SCLC) is a very aggressive neoplasm. Accurate and quick diagnosis is crucial to
initiate proper treatment.
The aim of this study was to establish the value of initial cytological diagnosis and to present typical cytological features of SCLC.
Material and methods: We reviewed 116 cases of SCLC confirmed by cytology in: bronchial brushings, pleural fluids, and
fine needle aspiration biopsies (FNAB).
Results: In 77% of SCLC cases, the diagnosis was established only by cytology; in 23% of cases, both cytological and
histological recognition was possible. Cytology of SCLC was initially uncertain in 12%, and histology was uncertain in 30% of
the cases. The morphology of SCLC cells was not uniform, and often a mixture of non-small atypical cells and bronchial
epithelial cells with signs of metaplasia was observed. There were four cases of combined cell type with large cell
carcinoma and two with adenocarcinoma. The main diagnostic problem was to distinguish small cell lung carcinoma from
lymphomas, and from cancer consisting of small cells with the cytological features of non-small cell carcinoma.
Conclusion: Diagnosis of SCLC in cytological smears is accurate, and final diagnosis is based on light microscopy. In the
differential diagnosis, other tumours of small cells have to be taken into account.
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Streszczenie
Wstęp: Drobnokomórkowy rak płuca (SCLC) należy do bardzo agresywnych nowotworów. Szybkie ustalenie właściwego
rozpoznania odgrywa kluczową rolę w podjęciu właściwej terapii.
Celem pracy była ocena roli badania cytologicznego we wstępnym rozpoznawaniu SCLC oraz przedstawienie typowych
cytologicznych cech tego nowotworu.
Materiał i metody: Analizie poddano 116 przypadków SCLC, które potwierdzono badaniem cytologicznym w następujących
materiałach: wymazy szczoteczkowe, płyn opłucnowy, biopsja aspiracyjna cienkoigłowa.
Wyniki: W 77% przypadków rozpoznanie SCLC było możliwe jedynie na podstawie badania cytologicznego; w 23% na
podstawie badania cytologicznego i histopatologicznego. Wynik badania cytologicznego był pierwotnie wątpliwy w 12%
przypadków, zaś histopatologicznego w 30%. Obraz morfologiczny SCLC nie był jednorodny — obserwowano formy miesza-
ne z obecnością komórek o cechach raka niedrobnokomórkowego oraz komórek nabłonka oskrzelowego z cechami metapla-
zji płaskonabłonkowej. Rozpoznano formy złożone SCLC z rakiem wielkokomórkowym w 4 przypadkach i rakiem gruczoło-
wym w 2 przypadkach. Głównym problemem diagnostycznym było odróżnienie raka drobnokomórkowego od chłoniaka
i raka z drobnych komórek o cechach cytologicznych raka niedrobnokomórkowego.
Wniosek: Klasyczne badanie cytologiczne w mikroskopie świetlnym umożliwia właściwe rozpoznanie SCLC. W diagnostyce
różnicowej należy brać pod uwagę inne nowotwory zbudowane z drobnych komórek.
Słowa kluczowe: drobnokomórkowy rak płuca, badanie cytologiczne, diagnoza
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Introduction
Lung cancer affects about 1.3 million people
worldwide and is responsible for more than 1 mil-
lion deaths per year. Two main histological types
are distinguished, namely non-small cell lung car-
cinoma (NSCLC) and small cell lung carcinoma
(SCLC) [1]. They both differ markedly in their bio-
logy and clinical course, with SCLC being highly
aggressive and highly responsive to chemothera-
py. By the end of the twentieth century SCLC com-
posed about 20% of lung carcinomas, although this
proportion has recently decreased to about 13% (as
reported in the US) [2]. Nevertheless, SCLC is still
responsible for the poor prognosis of lung mali-
gnancies as a whole. There are two main stages of
the disease, limited (LD) and extensive (ED), which
differ significantly in their prognosis and response to
treatment [3]. The introduction of new chemothera-
peutics promises improvement in SCLC therapy
[3, 4]. However, as in most malignancies, early dia-
gnosis (i.e. in the stage of LD) is the key point for opti-
mal therapeutic effect. Since the onset of the disease
is insidious, early diagnosis of SCLC is a rare entity.
The primary tumour is often a hilar mass or submu-
cosal infiltration [4], in many cases there are difficul-
ties in obtaining an adequate tissue sample for histo-
logical diagnosis, and only cytological diagnosis is
possible. The role of cytological diagnosis may be es-
sential in the early and accurate diagnosis of SCLC.
Many studies performed in the 1980s and 1990s con-
firmed the value of diagnostic cytology in lung can-
cer diagnosis [5–11]. However, apart from the text-
book descriptions, there are few papers discussing the
morphological pattern of SCLC in cytological samples
and the problems in differential diagnosis [1, 12, 13].
The aim of this work is to present the value of cytolo-
gy in the initial diagnosis of SCLC compared with hi-
stological biopsy, and to present the typical features
of SCLC in different cytological samples and the main
problems of differential diagnosis.
Material and methods
In this retrospective study we analyzed and
reviewed the cytological samples in which diagno-
sis of SCLC was established. We compared cytolo-
gical diagnosis with histological diagnosis, if per-
formed. During the diagnostic procedure, broncho-
scopy was performed in each patient and one or
more cytological and/or histological specimens
were taken. Informed consent was obtained from
each patient before the diagnostic procedures. The
examination was approved by the Ethics Commit-
tee of Warsaw Medical University. Bronchial bru-
shings (BB), fine needle aspirates (transbronchial
and transthoracic), and pleural fluid samples were
used for the cytological studies. BB and transbron-
chial needle aspiration biopsies (TBNA) were col-
lected (using a disposable bronchial cytology brush
— Con Med Endoscopic Technologies, Inc., USA
and a Wang transbronchial cytology needle 21 G
— Con Med Endoscopic Technologies, Inc., USA,
respectively) during awaken fibre-optic broncho-
scopy (performed with Pentax EB-1830T2, FB-
-19TV and FB-18V bronchoscopes). A fine needle
(21 G) was used to obtain aspirates from palpable
peripheral lymph nodes. For other extrapulmona-
ry metastases (e.g. thyroid gland, non- palpable le-
sions of neck, or tumours of visceral organs), ul-
trasound visualization was used. Transthoracic ne-
edle aspiration (TTNA) of peripheral lung tumo-
urs was performed under fluoroscopic or ultraso-
und guidance using 21 G needles (minimal tumo-
ur size 2 cm). After brushing or aspiration, cytolo-
gical smears were immediately fixed in alcohol and
then stained with haematoxylin and eosin. Pleural
fluid samples (100 ml), collected during diagnostic
thoracentesis, were centrifuged (10 min, 300 × g)
and then smears were prepared, fixed, and stained
as described above.
For SCLC diagnosis, the morphological crite-
ria defined by the WHO 2004 classification were
applied. This classification defines SCLC as „a ma-
lignant epithelial tumour consisting of small cells
with scant cytoplasm, ill-defined cell borders, fine-
ly granular nuclear chromatin, and absent or incon-
spicuous nucleoli. The cells are round, oval, and
spindle shaped, and nuclear molding is prominent”
(Fig. 1) [4, 12, 13]. All samples were reviewed by
two independent experienced pathologists. Uncer-
tain cases were resolved by a third expert review.
Figure 1. Typical features of small cell lung cancer cells in fine
needle aspiration biopsy (haematoxylin- eosin, × 400)
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Histological samples were collected with for-
ceps (PRECISOR bronchopulmonary disposable
biopsy forceps — ConMed Endoscopic Technolo-
gies, Inc., USA, diameter 1.8 or 2.3 mm) from en-
dobronchial lesions during fibre-optic bronchosco-
py. The slides were stained routinely with haema-
toxylin-eosin. As an additional method, immuno-
histochemistry (IHC) with monoclonal antibodies
was used. The following antibodies were used:
cytokeratins (CKAE1, E3), leukocyte common an-
tigen (LCA), chromogranin, and synaptophysin
(DAKO, Denmark).
Results
Of 4000 cytological examinations from respi-
ratory tracts performed from 2000 to 2006, we se-
lected cases diagnosed as SCLC. This included
cytological samples obtained from 116 patients
(53 F, 63 M, mean age 65 years). We have not pre-
sented any negative cytological examinations,
only those in which SCLC was confirmed. The-
refore, the number of samples and cases did not
differ. Figure 2 presents the source of the sam-
ples: the highest number came from bronchial
brushings (n = 36), while the lowest was from
pleural fluid (n = 12). Needle aspirates included:
transbronchial (n = 24), transthoracic (n = 12),
and FNAB of extrapulmonary metastases (n = 32).
Of these, 25 samples were taken from peripheral
lymph nodes, mainly from the supraclavicular gro-
up (17, i.e. 68% of all lymph nodes). Other sites
for FNAB included tumours of the thoracic wall,
thyroid gland, head, and neck. SCLC diagnosis was
certain in 102 cases; in 14 (12%) cases it was ini-
tially doubtful. Further analysis with the help of
a third expert led to the final diagnosis of SCLC
(6 cases) or SCLC combined with large carcinoma
(LC) in 4 cases. In 2 cases adenocarcinoma was
found in histological biopsy, which confirmed
another 2 combined types of SCLC. The doubtful
cases in each sample type and differential diagno-
sis taken into consideration are characterized
in Table 1.
In these 116 cases of SCLC diagnosed by cy-
tology, histological specimens were possible to
obtain only in 71 patients (61%), all of them be-
ing bronchial biopsies. In 39 of these samples
cancer was present, whereas in 32 (45%) there
were no malignant cells in the biopsy specimens.
Figure 2. Type of cytological material for light microscopy diagnosis of small cell lung carcinoma. FNAB — fine needle aspiration biopsy of
extrapulmonary metastases (supraclavicular lymph nodes being most frequent in our material), TBNA — transbronchial needle aspirates,
TTNA — transthoracic needle aspirates
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Table 1. Number of initially doubtful cases and the main causes of interpretative errors in cytological and histological dia-
gnosis of small cell lung carcinoma
Number of doubtful Differential diagnosis and interpretative problems
cases
Bronchial brushings [n = 36] 0 Squamous metaplasia
Transbronchial needle aspiration biopsy [n = 24] 3 Lymphoma
NSCLC of small cells
Transthoracic needle aspiration biopsy [n = 12] 2 NSCLC of small cells
Fine needle aspiration biopsy of metastases [n = 32] 8 Lymphoma
NSCLC of small cells
Pleural fluid [n = 12] 1 Metastases of a small cell neoplasm of other than lung cancer
Histological bronchial biopsy [n = 39] 12 Crush artefacts, inflammation
NSCLC — non-small cell lung carcinoma
Diagnosis of SCLC was certain in 25 cases (35%
of collected bronchial biopsies), in 2 adenocar-
cinoma was found, whereas in 12 cases the exa-
mination was non-conclusive due to crush arte-
facts. IHC was applied in 74% of the histologi-
cal biopsies, and in all of them SCLC was con-
firmed.
To summarize, in our group of 116 patients
with SCLC, in 89 cases (77%) the only diagnosis
was cytology (Fig. 3).
Bronchial brushing
Bronchial brushing represents an exfoliative
type of cytology with the presence of a mixture of
cancer cells and normal ciliated cells, a few basal
and goblet cells, and finally inflammatory cells
(neutrophils and lymphocytes). In our material,
smears of good quality revealed well-preserved
SCLC cells with typical cytological features easy
to recognize. If taken from the tumour surface, the
Figure 3. Cytological v. histological diagnosis of small cell lung
carcinoma (SCLC)
brushing samples contained numerous malignant
cells, sufficient for accurate diagnosis. Rarely, ne-
crotic masses or the presence of blood caused in-
terpretative problems. More often, nuclear sme-
aring was visible; this occurred when smears were
performed with too much force. However, this fe-
ature was useful as a clue suggestive of SCLC. This
nuclear smearing was usually accompanied by
well-preserved SCLC cells, and the latter were the
basis of the final diagnosis. Especially because the-
re was more than one slide from each patient, and
we never diagnosed SCLC only based on nuclear
smearing. Very often, small cells were accompa-
nied by epithelial cells with features of squamous
metaplasia (Fig. 4), dysplasia, or marked atypia
similar to the appearance of NSCLC. Thus, the
cytological picture might have been erroneously
interpreted as squamous cell carcinoma. In our
study, in 36 samples from bronchial brushings, no
uncertain cases were present.
Figure 4. Bronchial cells with features of squamous metaplasia
(arrow) and SCLC (haematoxylin-eosin, × 400)
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Transbronchial needle aspirates (TBNA)
SCLC often manifested as a mediastinal
mass, and distinguishing the primary tumour
from mediastinal lymph node involvement by
metastases was sometimes difficult. Metastases
to the lymph nodes were characterized by the
presence of mature and young forms of lympho-
cytes which coexisted with cancer cells. This was
the cause of the main problem in the differen-
tial diagnosis: SCLC versus lymphoma. Cancer
cells were larger in size than mature lymphocy-
tes, whereas lymphoma cells were similar to
SCLC cells in size. The main difference between
SCLC and lymphoma is the presence of necro-
sis, the absence of cytoplasm, and slightly more
pronounced cell polymorphism of cancer cells
versus lymphoma cells (which depends of the
kind of lymphoma). Nuclear smearing of cancer
cells but not of lymphocytes was observed,
which was useful in SCLC diagnosis.
Other interpretative challenges included di-
stinguishing SCLC from undifferentiated, anapla-
stic NSCLC and recognizing a combined type. In
our study, of 24 TBNAs, 3 were initially doubtful.
In two samples, we found the cells with morpho-
logy of NSCLC and we recognized the presence of
large cells (LC). LCs were larger than SCLCs and
had a visible cytoplasm, marked nuclear boarding,
and conspicuous nucleoli [14]. Finally, in these
two cases the combined type with LC was recogni-
zed while in the third case the SCLC was confir-
med by an independent expert.
Fine needle aspiration biopsy (FNAB)
of extrapulmonary metastases
FNABs of metastatic lesions usually contained
malignant cells and sometimes necrotic mass. In
SCLC, aspirates were full of cancer cells, and the
admixture of lymphocytes, even in lymph node
metastases, was not dominant. The morphology of
SCLC in the FNABs was typical, as described abo-
ve. Nuclear smearing was sometimes present. There
were no bloody samples. However, differential dia-
gnosis with lymphomas and NSCLC of small cells or
combined types had to be taken into consideration.
In this study, of 32 FNABs, 8 were initially doubtful.
In two of them, combined types with LC were final-
ly diagnosed and in the others the clinical data and
histological diagnosis of SCLC in bronchial biopsy
were useful in resolving the doubts.
Transthoracic needle aspiration (TTNA)
As in other FNABs, in TTNA samples cancer
cells were well preserved and presented typical
cytological features, as described above. Necrosis
and inflammatory cells with pulmonary macro-
phages were sometimes visible, but this did not
alter the very good quality of the smears. How-
ever, an admixture of blood caused some interpre-
tative problems. Initially there were 2 doubtful
cases of 12 TTNA from our patients, which need-
ed additional analysis and discussion with ano-
ther pathologist.
Pleural fluid
In our study, SCLC cells in the pleural fluid
were not numerous (Fig. 5). They were found in
mixtures of inflammatory and mesothelial cells
and formed small aggregates with cell molding. The
nuclei of the cancer cells were dark and the nucle-
ar structure was poorly visible. The cell diameter
seemed to be smaller than in samples from bron-
chial brushing or FNABs. In our study, 1 case in
12 was doubtful. In this case, only a few cancer cells
were found; however, the clinical data were very
useful to minimize the risk of misinterpretation.
Discussion
In this study, we presented the value of cyto-
logical diagnosis of SCLC and we confirmed its role
in the final diagnosis of this very aggressive neo-
plasm. We analyzed the results of the examination
of different kinds of cytological samples with spe-
cial attention paid to the morphology of cancer
cells. Difficulties in the differential diagnosis and
interpretative problems were discussed. SCLC re-
cognition was most accurate in bronchial brushing,
while in FNABs we found a relatively high num-
ber of uncertain cases.
The role of cytological diagnosis in lung can-
cer was established in the last thirty years. In 1982
Pilotti et al. presented very good results of diffe-
Figure 5. SCLC cells in pleural fluid (haematoxylin-eosin, × 400)
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rent cytological methods in lung cancer diagnosis
(samples included various materials, from sputum
to FNAB) [5–7, 15]. In recent decades, new techni-
ques of visualization and penetration of the bron-
chial tree and lung parenchyma, as well as new
methods of lung tissue sampling, have been deve-
loped. The main drawback of this work is that it
not very innovative, but we presented the role of
microscopic examination in SCLC, which still exi-
sts in the new era of diagnostic methods in ima-
ging and endoscopy. In spite of the development
of new techniques, light microscopic examination
remains the gold standard in lung cancer diagno-
sis. Lung cancer classification is based on the hi-
stological characteristics of tumours and focuses on
light microscopy. A review of the literature reve-
aled the lack of large studies concerning SCLC;
however, in studies on lung cancer cytopatholo-
gy, a high diagnostic accuracy for SCLC was no-
ted. Sharafkhaneh et al. reported a higher yield of
TBNA for SCLC than for NSCLC (87% v. 64%, re-
spectively) [16]. He explained this observation by
a lower cellular adherence of small cells and hi-
gher size of primary tumour resulting from the
aggressiveness of SCLC. On the other hand, in
a review by Schreiber et al., the authors showed
that misclassification in cytology was higher for
SCLC than for NSCLC: 9% v. 2%; however, the
accuracy in distinguishing these two types of can-
cer by cytology was high: from 0.94 to 1.00 (mean
0.98) in a large group of 6305 patients [10]. In this
résumé, the yield of cytobrushing had a higher sen-
sitivity than TBNA, which is in agreement with our
observation. Delgado et al., in a study on the role
of FNAB in the diagnosis of SCLC, described 100%
specificity and 67% sensitivity and a high ability
to distinguish SCLC from other lung malignancies.
He found 12% of all 259 samples to be SCLC [13].
In other studies, SCLC was confirmed in 8% to 70%
of all TBNA [11, 16, 17] and 8% of TTNA perfor-
med [8]. In the study of Steffee et al., a higher accu-
racy of SCLC than of NSCLC diagnosis was docu-
mented [11]. Recently, the role of ultrasound guided
biopsy has been widely presented [17–20].
There are two main types of errors in patholo-
gical diagnosis: sampling errors, when “the diagno-
stic material was not present on the slide”, and
interpretative errors [21]. In cytology, the latter
type is more frequent. As we have shown, some
features of small carcinoma cells need to be taken
into consideration in light microscopy diagnosis
of SCLC. In samples from bronchial brushing and
FNAB, the cell morphology is well preserved; how-
ever, the admixture of other cells may cause im-
portant interpretative difficulties — metaplastic
bronchial epithelial cells in brushing [22] or lym-
phocytes in FNAB [20] serve as examples. The
morphology of the same small cancer cells varied
in different samples. The main difference was be-
tween cells in FNAB and body fluids. Presently,
the method of liquid cytology is widely used, and
this preparation may influence the differences in
the cell morphology [23].
At the time of SCLC diagnosis, extensive di-
sease is recognized in 70% of the patients [3]. Very
often FNAB of a metastatic tumour is the first dia-
gnostic procedure, and in some exceptional cases
may be the final diagnosis before treatment. In our
study, accurate diagnosis of SCLC was establi-
shed by FNAB of extrapulmonary metastases in
27.5% of the cases. Metastases to the supracla-
vicular lymph nodes were most frequent. In
a review by Jackman, the frequency of this site
of metastases varied from 17% at presentation to
42% in autopsy [4].
Pleural fluid rarely serves as a good material
for the initial diagnosis of SCLC, more often for the
confirmation of cancer spread. Involvement of the
pleura was reported in 20–30% of patients with
SCLC [4]. Small carcinoma cells may be detected
accidentally during the diagnosis of pleural effu-
sion. In our series, SCLC cells in pleural fluid are
not numerous. The presence of small carcinoma
cells may indicate metastases from other small cell
tumours (such as breast carcinoma), and therefore
the interpretation of pleural fluid cytology should
be cautious, and clinical data always needs to be
considered in the final diagnosis [24].
As we have shown in our results, it may be
difficult to distinguish SCLC from undifferentia-
ted, anaplastic NSCLC. Delgado et al. noted simi-
lar difficulties in the differentiation of SCLC and
poorly differentiated squamous cell and large cell
lung carcinoma [13]. An admixture of cells with
features of non-small cell origin may indicate
a combined type of SCLC (Fig. 6). SCLC combined
with non-small cell carcinoma is quite frequent
(estimated at 10–26%) and is currently classified
as a subtype of SCLC [1, 14]. The combined type
of SCLC is defined as cancer of small cell origin in
which at least 10% of the cancer tissue is compo-
sed of large carcinoma cells [12]. A mixture with
large carcinoma (LC) or large cell neuroendocrine
lung carcinoma (LCNEC) is reported to be the most
frequent. In a series of 113 neuroendocrine lung
carcinomas, Asamura et al. found 26% combined
and, of these, 13% with LCNEC; 14 cases were
borderline [14]. As mentioned above, combined
SCLC is characterized by the presence of at least
10% of large cells in the cancer tissue. Thus, in the
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cytology of small samples this admixture may be
missed. In our material there were four combined
cell types, all with LC and all in the needle aspirates
of metastases. LC cells are larger than SCLC and have
a visible cytoplasm, marked nuclear boarding, and
conspicuous nucleoli [25]. Cell size alone seems to
be insufficient as a criterion for small cell/large cell
differentiation, as proposed by some authors [14]. In
spite of the some initial problems, we recognized
these cells among SCLC cells. Even if combined type
SCLC is not diagnosed, clinically this may have lit-
tle significance: no difference between pure small cell
and the combined type in the prognosis was obse-
rved [11, 12, 14]. Nitadori et al. showed the useful-
ness of immunohistochemistry in LCNEC diagnosis:
a higher expression of cytokeratines CK7, 18, E-cad-
herin, and beta-catenin in the LCNEC cells when
compared with SCLC [26] was noted.
The diagnostic yield of histological biopsy in
SCLC is disappointing: Clee et al. reported 25% [9];
in our study it reached 35%. The main problem in
histology is sampling error, usually due to the pri-
mary tumour localization and crush artefacts [12].
In our series of 71 bronchial biopsies, cancer tis-
sue was found in 39 samples, and in 12 of them
SCLC was not certain. In the study of Nicholson,
crush artefacts caused interpretative problems in
14% of the cases [12]. In uncertain histological
cases, certain antibodies may be used to increase
the specificity. These include cytokeratins to di-
stinguish SCLC from lymphomas and CD56-
-NCAM, synaptophysin, and chromogranin to con-
firm the neuroendocrine origin of the small cells
[1]. Recently, a positive reaction of thyroid trans-
cription factor 1 (TTF1) with SCLC cells was fo-
und in about 80–90%, which may be of value in
differential diagnosis with NSCLC and carcinoid.
However, in the opinion of many pathologists, the
histological diagnosis of SCLC should be based on
light microscopy, and immunohistochemistry (IHC)
is not generally recommended [1, 4, 12]. Cytologi-
cal samples are usually too small to apply IHC.
However, sometimes it may be useful and necessa-
ry in differential diagnosis with lymphomas.
We conclude that the diagnosis of SCLC in
cytological smears is accurate, and final diagnosis
may be based on light microscopy. In the differen-
tial diagnosis, other tumours of small cells have to
be taken into account.
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